A detailed history of Pine Bridge Investments, L.P. transactions in Catalent, Inc. stock. As of the latest transaction made, Pine Bridge Investments, L.P. holds 19,932 shares of CTLT stock, worth $1.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,932
Previous 20,025 0.46%
Holding current value
$1.27 Million
Previous $1.13 Million 7.19%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$56.16 - $60.96 $5,222 - $5,669
-93 Reduced 0.46%
19,932 $1.21 Million
Q2 2024

Aug 14, 2024

SELL
$53.58 - $57.02 $577,270 - $614,333
-10,774 Reduced 34.98%
20,025 $1.13 Million
Q1 2024

May 14, 2024

BUY
$42.56 - $59.82 $290,472 - $408,271
6,825 Added 28.47%
30,799 $1.74 Million
Q4 2023

Feb 13, 2024

BUY
$32.18 - $46.57 $204,857 - $296,464
6,366 Added 36.15%
23,974 $1.08 Million
Q3 2023

Nov 14, 2023

BUY
$44.2 - $50.2 $778,273 - $883,921
17,608 New
17,608 $801,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Pine Bridge Investments, L.P. Portfolio

Follow Pine Bridge Investments, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.